Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study

Sanfélix-Genovés, José; Peiró, Salvador; Sanfélix-Gimeno, Gabriel; Giner, Vicente; Gil, Vicente; Pascual, Manuel; Fluixá, Carlos; Fuertes, Antonio; Hurtado, Isabel; Ferreros, Inmaculada
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p153
Academic Journal
Background: Today, while there are effective drugs that reduce the risk of osteoporotic fracture, yet there are no broadly accepted criteria that can be used to estimate risks and decide who should receive treatment. One of the actual priorities of clinical research is to develop a set of simple and readily-available clinical data that can be used in routine clinical practice to identify patients at high risk of bone fracture, and to establish thresholds for therapeutic interventions. Such a tool would have high impact on healthcare policies. The main objective of the ESOSVAL-R is to develop a risk prediction scale of osteoporotic fracture in adult population using data from the Region of Valencia, Spain. Methods/Design: Study design: An observational, longitudinal, prospective cohort study, undertaken in the Region of Valencia, with an initial follow-up period of five years; Subjects: 14,500 men and women over the age of 50, residing in the Region and receiving healthcare from centers where the ABUCASIS electronic clinical records system is implanted; Sources of data: The ABUCASIS electronic clinical record system, complemented with hospital morbidity registers, hospital Accidents & Emergency records and the Regional Ministry of Health's mortality register; Measurement of results: Incident osteoporotic fracture (in the hip and/or major osteoporotic fracture) during the study's follow-up period. Independent variables include clinical data and complementary examinations; Analysis: 1) Descriptive analysis of the cohorts' baseline data; 2) Upon completion of the follow-up period, analysis of the strength of association between the risk factors and the incidence of osteoporotic fracture using Cox's proportional hazards model; 3) Development and validation of a model to predict risk of osteoporotic fracture; the validated model will serve to develop a simplified scale that can be used during routine clinical visits. Discussion: The ESOSVAL-R study will establish a prediction scale for osteoporotic fracture in Spanish adult population. This scale not only will constitute a useful prognostic tool, but also it will allow identifying intervention thresholds to support treatment decision-making in the Valencia setting, based mainly on the information registered in the electronic clinical records.


Related Articles

  • Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia. Whyte, Michael P. // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1132 

    The article presents an overview of research which examined the association between femoral fractures and hypophosphatasia and femoral fractures and the use of the bisphosphonate alendronate which is used to treat osteoporosis in older people. A discussion of the causes of hypophosphatasia is...

  • Assessment of fracture risk. Kanis, John A.; Borgstrom, Frederik; de Laet, Chris; Johansson, Helena; Johnell, Olof; Jonsson, Bengt; Oden, Anders; Zethraeus, Niklas; Pfleger, Bruce; Khaltaev, Nikolai // Osteoporosis International;Jun2005, Vol. 16 Issue 6, p581 

    The diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD). There are a number of clinical risk factors that provide information on fracture risk over and above that given by BMD. The assessment of fracture risk thus needs to be distinguished from diagnosis to take...

  • STRETCH YOUR LEGS, SAVE YOUR HIPS.  // Prevention;Mar2006, Vol. 58 Issue 3, p34 

    A report from the International Osteoporosis Foundation shows that women who sit for more than 9 hours a day are 50% more likely to break a hip than those who sit less than 6 hours a day.

  • BMD screening in older women: Initial measurement and testing interval. Lewiecki, E Michael; Laster, Andrew J; Miller, Paul D; Bilezikian, John P // Journal of Bone & Mineral Research;Apr2012, Vol. 27 Issue 4, p739 

    The author discusses the need for bone density testing in determining the individual's bone mineral density (BMD) for osteoporosis. Osteoporosis is major health issue as it affects more than 200 million people and the author believes the decline of BMD testing is responsible for this. The author...

  • Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization. Bala, Yohann; Depalle, Baptiste; Farlay, Delphine; Douillard, Thierry; Meille, Sylvain; Follet, Helene; Chapurlat, Roland; Chevalier, Jérôme; Boivin, Georges // Journal of Bone & Mineral Research;Apr2012, Vol. 27 Issue 4, p825 

    In the treatment of postmenopausal osteoporosis (PMOP), the use of alendronate (ALN) leads to a decrease in the risk of vertebral and nonvertebral fractures. To explore the possible adverse effects of prolonged ALN therapy, we studied the effects of 8 ± 2 years (6-10 years) of ALN treatment...

  • Prediction of fracture risk in men: A cohort study. Byberg, Liisa; Gedeborg, Rolf; Cars, Thomas; Sundström, Johan; Berglund, Lars; Kilander, Lena; Melhus, Håkan; Michaëlsson, Karl // Journal of Bone & Mineral Research;Apr2012, Vol. 27 Issue 4, p797 

    FRAX is a tool that identifies individuals with high fracture risk who will benefit from pharmacological treatment of osteoporosis. However, a majority of fractures among elderly occur in people without osteoporosis and most occur after a fall. Our aim was to accurately identify men with a high...

  • BMD screening in older women: Initial measurement and testing interval. Gourlay, Margaret L; Preisser, John S; Lui, Li-Yung; Cauley, Jane A; Ensrud, Kristine E // Journal of Bone & Mineral Research;Apr2012, Vol. 27 Issue 4, p743 

    The author discusses bone mineral density (BMD) testing in women ages 65 years and older which can lessen the probability of osteoporosis and its complications. It is suggested that the frequency and interval of dual-energy X-ray absorptiometry (DXA), the method for determining osteoporosis,...

  • CPOMS is cost saving and prevents future hip fractures.  // PharmacoEconomics & Outcomes News;Apr2015, Vol. 725 Issue 1, p12 

    The article presents a study on the cost effectiveness of Clinical Pharmacy Osteoporosis Management Service (CPOMS) during post-fracture care in postmenopausal women and its effectiveness in preventing future hip fractures in comparison to care given by a nurse.

  • Bisphosphonates for prevention of hip fractures effective but costly.  // PharmacoEconomics & Outcomes News;Apr2015, Vol. 725 Issue 1, p7 

    The article presents a study which determines that biophosphonates are effective in preventing hip fractures in elderly women, after they have been used against wrist fractures but with a substantial cost.

  • Childhood bone density studied at UBC. Kent, Heather // CMAJ: Canadian Medical Association Journal;06/16/98, Vol. 158 Issue 12, p1596 

    Discusses a childhood bone density study conducted by researchers from the University of British Columbia. Details on type of children used in the study; Belief that children are becoming less physically active; The issue of children being more acceptable to osteoporosis later in life.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics